Related Experiment Videos
Langerhans' cells and cutaneous necrotizing vasculitis
T M Lotti1, I Ghersetich, C Comacchi
1Department of Dermatology, University of Florence, Italy.
Clinics in Dermatology
|December 11, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2016
Reactive arthritis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Idiopathic guttate hypomelanosis: an electron microscopy study.
Journal of the European Academy of Dermatology and Venereology : JEADV·2014
Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice.
The British journal of dermatology·2014
Vitiligo: recent insights and new therapeutic approaches.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2012
Melasma.
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia·2012
Art, Decadence, and Dermatology in 1920s Berlin: Three Portraits by Christian Schad.
Clinics in dermatology·2026
Art and the Heart. New Concepts in Heart Failure.
Clinics in dermatology·2026
Fast-tracking dermatologic care for "VIP" patients: ethical concerns and practical approaches.
Clinics in dermatology·2026
Ethics of suggesting image-guided superficial radiation therapy in the pathology report.
Clinics in dermatology·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026